Global Blog

Why DE&I Policies Are More Essential Than Ever

Diversity, Equity, and Inclusion (DE&I) are not just buzzwords or isolated initiatives — they represent fundamental pillars for any organization striving to innovate, thrive, and...

How AI Use Cases are shaping the Future of Marketing: Insights from Artefact’s keynote at CDP World 2024

CDP World was particularly exciting this year mainly because a huge theme of the event was around maximizing the potential of AI and GenAI in...

AI Breathes New Life into Clinical Trials: Perspectives and Challenges

Artificial intelligence is transforming the world of clinical trials, promising to cut drug development timelines in half.

AI for Efficiency program : Transforming BNP Paribas Commercial Banking Through AI

In a context where technological innovation is redefining standards of performance and efficiency, BNP Paribas' "AI for Efficiency" program, developed in collaboration with Artefact, stands...

Orange bets on AI for network optimization, automation

Artefact mentioned in this interview from Brelotte Ba, deputy CEO of Orange Middle East and Africa, by Connecting Africa, on Orange's latest AI and GenAI...

Compound AI Systems: The Future of Specialized Intelligence

Since its explosive emergence in mid-2022, generative AI has quickly captured global attention. What initially centered on the language modality has since expanded into exciting...

Is GenAI hype dying? – Why now is the best time to build

Generative AI is a game-changer with applications across industries. Companies are actively discussing it, venture capitalists are heavily investing, and both employees and users are...

Is Preference Alignment Always the Best Option to Enhance LLM-Based Translation? An Empirical Analysis

Neural metrics for machine translation (MT) evaluation have become increasingly prominent due to their superior correlation with human judgments compared to traditional lexical metrics

Unleashing the power of AI in Clinical Trials: Key Insights from PFIZER and ARTEFACT - AI for Health Summit

The discussion revolved around the transformative role of AI in clinical trials, supported by insights from Pfizer and Artefact, and highlighted in their collaborative white...

CLARIANE and CNES MEDES at AI for Health - Preventing frailty and AI-geing well

The conversation explores how data and AI are transforming elder care, focusing on the rising demographic of seniors in France, where 20% of the population...

SANOFI, AWS, IKTOS, ELAIA and MIND GROUP at AI for Health - The generative AI revolution for drug discovery

This roundtable explored the transformative role of GenAI in drug discovery, highlighting its potential to optimize processes, accelerate timelines, and foster collaboration in the pharmaceutical...

ROCHE, PULSELIFE and SALESFORCE at the AI for Health Summit - Omni-channel engagement of HCPs in the Age of GenAI

The roundtable focused on the transformative potential of AI and (GenAI) in omni-channel engagement for healthcare professionals (HCPs). The discussion explored how AI reshapes interactions,...